Tasigna
Payments companies reported to CMS as associated with Tasigna. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tasigna, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tasigna
These are the largest totals companies reported as associated with Tasigna. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Myrna Andino Camacho | Bayamon, PR | Hematology & Oncology | $303.44 |
| Evelyn Fonseca Rivera | Caguas, PR | Hematology & Oncology | $276.59 |
| Kylee Maliwauki | Provo, UT | Family | $213.92 |
| Edgardo Rodriguez Monge | Caguas, PR | Hematology & Oncology | $200.15 |
| Carlos Mendez Serrano | Caguas, PR | Hematology & Oncology | $200.15 |
| Maribel Cotto | Caguas, PR | Hematology & Oncology | $200.15 |
| Gregory Chipman | American Fork, UT | Medical Oncology | $193.25 |
| Luis Cotto Santana | San Juan, PR | Hematology & Oncology | $186.46 |
| Ryon Nakasone | Honolulu, HI | Hematology & Oncology | $176.33 |
| Karen Rowan | Honolulu, HI | Family | $174.56 |
Prescribed Tasigna?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.